The prevalence of stress urinary incontinence after prostatic surgery for benign disease is 0-2% and 5-35% after surgery for malignant disease. After radical prostatectomy for prostate cancer spontaneous improvement of stress incontinence occurs up to 1 year after surgery. Medical treatment with doloxetine (a serotonine-noradrenaline-reuptake inhibitor) and minimal invasive treatments like urethral bulking and male sling procedures are only effective against minor stress incontinence. Implantation of artificial urethral sphincter prosthesis remains gold standard for effective treatment and lasting effect.
Download full-text PDF |
Source |
---|
Clin Rehabil
January 2025
Physiotherapy Unit, IRCCS Humanitas Research Hospital, Milan, Italy.
Objective: To investigate the effects of a home-based pelvic floor muscle training with and without action and cue observation on urinary incontinence after prostatectomy.
Design: Two-armed single-blind randomized controlled trial.
Setting: Humanitas Research Hospital, Milan, Italy.
Int J Impot Res
January 2025
Department of Urology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.
Prostate cancer treatment-related erectile dysfunction and stress urinary incontinence are commonly treated with inflatable penile prosthesis (IPP) or artificial urinary sphincter (AUS). Given the association with androgens and penile/urethral health, we aim to evaluate whether patients on androgen deprivation therapy (ADT) undergoing IPP or AUS surgery are at increased risk for reintervention, complication, or infection. We queried the TriNetX database for adult males receiving IPP or AUS.
View Article and Find Full Text PDFObjectives: This study aimed to assess postoperative decision regret (DR) after precision prostatectomy (PP), a novel subtotal surgical technique for prostate cancer (PCa) that involves the preservation of the unilateral capsule and seminal vesicle, and to identify factors predictive of DR after PP.
Materials And Methods: After a shared decision-making process, 128 patients underwent PP for the treatment of localised PCa. Given the subtotal nature of the surgery, patients were informed about the possibility of a detectable prostate-specific antigen and secondary treatment.
BJUI Compass
January 2025
Miller School of Medicine Desai Sethi Urology Institute, University of Miami Miami FL USA.
Objectives: To evaluate the safety and feasibility of "en-bloc" Holmium Laser Enucleation of the Prostate (HoLEP) with trainee involvement in patients with prostates larger than 200 cc.
Patients And Methods: A retrospective analysis was conducted on patients undergoing HoLEP using the "en-bloc" technique for prostate sizes > 200 cc between July-2017 and December-2023 at an academic teaching hospital. Perioperative data was collected, including patient demographics, clinical parameters, operative details and functional outcomes.
Cureus
December 2024
Urology, Private Practice, Eskişehir, TUR.
Background: We compared the safety and efficacy of holmium laser enucleation of the prostate (HoLEP) and transurethral resection of the prostate (TURP) in elderly men (aged ≥75 years) with benign prostatic hyperplasia (BPH).
Methods: A retrospective analysis of 151 patients (HoLEP: 72; TURP: 79) was conducted. Preoperative and postoperative parameters, including prostate size, International Prostate Symptom Score (IPSS), catheterization duration, hospital stay, and perioperative complications (incontinence and dysuria), were analyzed.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!